Rare Cancer Research & Support - TargetCancer Foundation
264510094
2009
Cambridge, MA 02139
targetcancer.org
targetcancer
Podobné organizace
The Katie Moore Foundation Inc |
|
Gateway for Cancer Research Inc. |
|
United Cancer Front |
|
RARE CANCER RESEARCH FOUNDATION |
|
Cancer Research Collaboration Inc |
Podobné organizace global
CANCER 52 |
|
ACT FOR CANCER |
|
Cure Cancer Australia Foundation |
|
Rare Cancers Australia Ltd |
|
UNISERVE FOR CANCER LTD |
Podobně sociální sítě (2076)
Romodrom, o.p.s.2099 |
|
Kultura v Horní Bříze, z. s.2100 |
|
Kytarový festival Mikulov / Guitar Festival Mikulov, z.s.2100 |
|
MAMINY S RAKOVINOU, z.s.2100 |
|
Někdo Ti uvěří, z. s.2100 |
Více Výzkum rakoviny
Nadační fond HippokratesPraha |
|
CZECHIMPLANT, z.s.Kladno |
|
CZECH MDS GROUP, z.s.Praha |
|
Heřmanského nadace hematologické onkologiePraha |
|
Sdružení pro srdeční rytmus, spolekPraha |
Novinky
Every cut, every delay and every firing has an impact on patients. Patients’ experiences are critical to letting decision makers understand that cancer is not political and we cannot afford to lose the incredible progress that is being made in research, especially for rare cancers. Stay tuned for ways that you can make your voice heard and play a part to #saverarecancerresearch #rarecancer #rarecancerresearch #medicalresearch (fb)
Call for Abstracts- the deadline is fast approaching! tinyurl.com/TCFabstract25 TargetCancer Foundation invites early-career investigators (within 5 years of fellowship or terminal degree) to submit abstracts for presentation at our annual Think Tank on Advancing Precision Medicine in Rare Cancers, being held on October 29, 2025. The deadline for submissions is July 31. This event brings together emerging researchers and leading experts to foster collaboration and highlight innovative research in rare cancers across clinical, translational, epidemiological, and basic science domains. We encourage early-career investigators to contribute to this important conversation and help drive progress in the rare cancer space. Why Submit? • Share your research with leaders in the field • Gain valuable feedback and mentorship opportunities • Build your professional network • Selected abstracts will be invited for oral or poster presentations at the event #CallForAbstracts #earlycareerinvestigators #PrecisionMedicine #rarecancer (fb)
Poslední komentáře
Incredible work, TargetCancer Foundation! Your commitment to providing effective treatments for those with rare cancers truly gives hope to so many. Keep pushing for innovation and change! 💪💖detail |
|
Absolutely inspired by all the advancements you’re making in rare cancer research! Thank you for empowering patients and giving them a chance to live their best lives. Together, we can make a difference! 🌟👏detail |
Poslední diskuze
1. What innovative strategies can NGOs like TargetCancer Foundation implement to improve patient recruitment for clinical trials in rare cancers?Odpovědí: 3, Naposledy před 1 den detail |
|
2. How can collaboration between various stakeholders enhance the development of personalized treatment options for individuals with rare cancers?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4
30
4.5
Cambridge
O společnosti
- H30 -
Advancing Innovation in Rare Cancers At TargetCancer Foundation we believe everyone diagnosed with a rare cancer should have effective treatments and a chance to live. Breaking Down Barriers in Rare Cancer Research Since 2009 TargetCancer Foundation works to advance the development of more effective and personalized treatments for people with rare cancers. We do this by Driving innovative research Connecting the rare cancer community Empowering people with rare cancers TargetCancer Foundations impact goes beyond the numbers. Launched 1st fullyremote precision medicine clinical trial for rare cancer Enrolling 400 people with rare cancers in TCF001 TRACK trial Convened Thousands of rare cancer experts through TCFs scientific meetings Dedicated 15 years and millions of dollars to drive advances in rare and underresourced cancers Cocreating New Rare Cancer Tools and Pathways for Discovery We convene and collaborate with key stakeholders both organizations and individuals to advance our shared goal of more effective and personalized treatments for everyone living with rare cancers.
Výzkum rakoviny